Blum Robert I's Form 4 filing
Cytokinetics Inc (CYTK) · filed Jun 17, 2024
- Accession no.
- 0001127602-24-018855
- Filed
- Jun 17, 2024
- Trade date
- Jun 17, 2024
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $1.18M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Blum Robert ICIK 0001288859 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2024 | Common Stock | SSaleDisposed | −11,551 | $52.60 | −$607,582.6 | 427,594 | Direct | |
| Jun 17, 2024 | Common Stock | SSaleDisposed | −10,949 | $52.59 | −$575,807.91 | 416,645 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.